Eledon Pharmaceuticals, Inc. Goodwill
Eledon Pharmaceuticals, Inc. (ELDN) had Goodwill of $0 as of 2023-12-31, per its 10-K/A filed 2024-08-19.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:Goodwill · last filed 2024-08-19
- 2023-12-31: Goodwill $0.00.
- 2022-12-31: Goodwill $0.00.
- 2022-09-30: Goodwill $48.65M.
- 2022-06-30: Goodwill $48.65M.
| Period end | Goodwill |
|---|---|
| 2023-12-31 | $0.00 10-K/A · filed 2024-08-19 |
| 2022-12-31 | $0.00 10-K/A · filed 2024-08-19 |
| 2022-09-30 | $48.65M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $48.65M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $48.65M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $48.65M 10-K/A · filed 2024-08-19 |
| 2021-09-30 | $48.65M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $48.65M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $48.65M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $48.65M 10-K · filed 2023-03-30 |
| 2020-09-30 | $44.47M 10-Q · filed 2020-11-16 |
| 2019-09-30 | $1.87M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $1.87M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $1.87M 10-Q · filed 2019-05-14 |
| 2018-12-31 | $1.87M 10-K · filed 2020-03-17 |
| 2018-09-30 | $1.87M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $1.87M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $1.87M 10-Q · filed 2018-05-11 |
| 2017-12-31 | $1.87M 10-K · filed 2020-03-17 |
| 2017-09-30 | $1.87M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $1.87M 10-Q · filed 2017-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |